These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34717731)

  • 1. Risk factors for development of nephropathy in patients with a diabetic Charcot foot.
    Jansen RB; Holstein PE; Jørgensen B; Møller KK; Svendsen OL
    BMC Res Notes; 2021 Oct; 14(1):403. PubMed ID: 34717731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of diabetic foot Charcot arthropathy: a case-control study at a Malaysian tertiary care centre.
    Fauzi AA; Chung TY; Latif LA
    Singapore Med J; 2016 Apr; 57(4):198-203. PubMed ID: 27075668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charcot arthropathy of the foot and ankle associated with rheumatoid arthritis.
    Grear BJ; Rabinovich A; Brodsky JW
    Foot Ankle Int; 2013 Nov; 34(11):1541-7. PubMed ID: 23900228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone.
    Sohn MW; Lee TA; Stuck RM; Frykberg RG; Budiman-Mak E
    Diabetes Care; 2009 May; 32(5):816-21. PubMed ID: 19196882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Charcot Foot: A Case Report.
    Phillips A; Rice L
    Nephrol Nurs J; 2022; 49(5):419-425. PubMed ID: 36332122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and complications after treatment of acute diabetic Charcot foot.
    Jansen RB; Jørgensen B; Holstein PE; Møller KK; Svendsen OL
    J Diabetes Complications; 2018 Dec; 32(12):1141-1147. PubMed ID: 30301593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amputation and mortality frequencies associated with diabetic Charcot foot arthropathy: a meta-analysis.
    Yammine K; Boulos K; Assi C; Hayek F
    Foot Ankle Surg; 2022 Dec; 28(8):1170-1176. PubMed ID: 36028441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study.
    Jansen RB; Christensen TM; Bülow J; Rørdam L; Holstein PE; Jørgensen NR; Svendsen OL
    J Diabetes Complications; 2018 Feb; 32(2):164-170. PubMed ID: 29196119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic nephropathy but not HbA1c is predictive for frequent complications of Charcot feet - long-term follow-up of 164 consecutive patients with 195 acute Charcot feet.
    Sämann A; Pofahl S; Lehmann T; Voigt B; Victor S; Möller F; Müller UA; Wolf G
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):335-9. PubMed ID: 22421981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of bone metabolism and developments in medical treatment of the diabetic Charcot foot.
    Jansen RB; Svendsen OL
    J Diabetes Complications; 2018 Jul; 32(7):708-712. PubMed ID: 29857955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of total contact casting for resolution of acute Charcot foot: a retrospective cohort study.
    Griffiths DA; Kaminski MR
    J Foot Ankle Res; 2021 Jun; 14(1):44. PubMed ID: 34130722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arthrodesis as an early alternative to nonoperative management of charcot arthropathy of the diabetic foot.
    Simon SR; Tejwani SG; Wilson DL; Santner TJ; Denniston NL
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):939-50. PubMed ID: 10901308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic Foot Considerations Related to Plantar Pressures and Shear.
    Martin JK; Davis BL
    Foot Ankle Clin; 2023 Mar; 28(1):13-25. PubMed ID: 36822683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confronting a dramatic situation: the charcot foot complicated by osteomyelitis.
    Dalla Paola L
    Int J Low Extrem Wounds; 2014 Dec; 13(4):247-62. PubMed ID: 25123373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.
    Jeffcoate WJ
    Curr Diab Rep; 2005 Dec; 5(6):430-5. PubMed ID: 16316593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charcot foot in a Hong Kong Chinese diabetic population.
    Leung HB; Ho YC; Wong WC
    Hong Kong Med J; 2009 Jun; 15(3):191-5. PubMed ID: 19494374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the diabetic Charcot foot.
    Frykberg RG; Mendeszoon E
    Diabetes Metab Res Rev; 2000; 16 Suppl 1():S59-65. PubMed ID: 11054891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of the Charcot foot.
    Frykberg RG; Belczyk R
    Clin Podiatr Med Surg; 2008 Jan; 25(1):17-28, v. PubMed ID: 18165108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.
    Nehring P; Mrozikiewicz-Rakowska B; Maroszek P; Sobczyk-Kopcioł A; Krzyżewska M; Płoski R; Karnafel W
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):31-4. PubMed ID: 24203651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of body mass index in acute charcot neuroarthropathy.
    Ross AJ; Mendicino RW; Catanzariti AR
    J Foot Ankle Surg; 2013; 52(1):6-8. PubMed ID: 23260985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.